Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 104 M114 M105 M133 M115 M130 M 483 M Research & development —————— — Operating income 81 M275 M564 M7 M847 M1.17 B 2.59 B Non-Operating Income, Total -82 M-29 M-36 M-48 M-8 M4 M -88 M Interest expense, net of interest capitalized 49 M53 M51 M64 M41 M20 M 176 M Non-Operating Income, excl. Interest Expenses -29 M-36 M-34 M-43 M-23 M1 M -99 M Unusual income/expense -53 M7 M-2 M-5 M15 M3 M 11 M Pretax income -1 M246 M528 M-41 M839 M1.17 B 2.5 B Equity in earnings 11 M10 M6 M6 M8 M6 M 26 M Taxes 1 M36 M123 M-14 M189 M279 M 577 M Non-controlling/minority interest 2 M2 M2 M1 M2 M1 M 6 M After tax other income/expense 23 M31 M-29 M7 M24 M-23 M -21 M Net income before discontinued operations -4 M208 M403 M-28 M648 M892 M 1.92 B Discontinued operations —————— — Net income -4 M208 M403 M-28 M648 M892 M 1.92 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -5 M206 M400 M-27 M642 M885 M 1.9 B Basic earnings per share (Basic EPS) -0.021.12.15-0.153.564.93 10.49 Diluted earnings per share (Diluted EPS) -0.021.12.15-0.153.564.93 10.49 Average basic shares outstanding 188.49 M188.11 M186.5 M186.47 M180.65 M179.42 M — Diluted shares outstanding 188.49 M188.11 M186.5 M186.47 M180.65 M179.42 M — EBITDA -5.75 B-5.77 B-5.66 B-6 B-4.97 B-7.55 B -24.18 B EBIT -5.98 B-6 B-5.89 B-6.23 B-5.2 B-7.78 B -25.1 B Cost of revenue 5.96 B6.16 B6.35 B6.11 B5.93 B8.82 B 27.2 B Other cost of goods sold 5.96 B6.16 B6.35 B6.11 B5.93 B8.82 B 27.2 B Depreciation & amortization (cash flow) 225 M226 M230 M228 M229 M228 M 915 M